Kenneth I. Kaitin
Independent DirectorDr. Kenneth I. Kaitin, Ph. D., serves as a Professor of Medicine, Pharmacology & Experimental Therapeutics at Tufts University School of Medicine and has been a Director of Tufts Center for the Study of Drug Development since 1998. Dr. Kaitin served as Associate Professor of Medicine at Tufts University School of Medicine. He served as an Editor-in-Chief of Drug Information Journal. He is an internationally recognized expert on the science of drug development. He served as the President of the Drug Information Association from 1997 to 1998. Dr. Kaitin also holds appointments as Advisory Professor at Shanghai Medical College of Fudan University in Shanghai, China Visiting Executive at the Tuck School of Business at Dartmouth College. He has been Faculty of European Center for Pharmaceutical Medicine at the University of Basel since 1999. An internationally recognized expert on drug development science and policy, Dr. Kaitin writes and speaks regularly on factors that contribute to the slow pace and high cost of pharmaceutical R&D and efforts to improve the development process. He has been an Independent Director of Curis, Inc. since November 2003. Dr. Kaitin joined the Curis, Inc. in November 2003. Dr. Kaitin serves as a Director of Bio-Tree Systems, Inc., Centerphase Solutions, Inc. and New England Healthcare Institute. He has been a Member of Scientific Advisory Board at Humedica, Inc. since November 2009. He serves as a Member of Advisory Board of Relay Technology Management, Inc. Dr. Kaitin served as a Director of Phase Forward Inc. from November 7, 2007 to August 11, 2010. Dr. Kaitin served as a Director of Erevnos Corporation. He is frequently quoted in the business and trade press on R&D trends in the research based pharmaceutical and biotechnology industries. His work covers the entire value chain of pharmaceutical innovation, from discovery to manufacturing and sales and marketing. He has written extensively on a broad range of drug development issues and has provided public testimony before the U. S. Congress in hearings on pharmaceutical innovation and FDA reform. He was President of the Drug Information Association. Dr. Kaitin is Editor-in-Chief of Expert Review of Clinical Pharmacology. He is on the editorial boards of a number of peer review journals and he serves on the boards of Directors and scientific advisory boards of several public, private and not-for-profit life sciences companies and organizations. In 2011, Dr. Kaitin received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators. Dr. Kaitin received a B. S. from Cornell University and an M. S. and Ph. D. in Pharmacology from the University of Rochester.
Positions
- Company NameCuris, Inc.Stock CodeCRISPositionIndependent DirectorColleagues
- JEJames E. DentzerPresident, CEO, Secretary, Treasurer & Director
- MDMartyn D. GreenacreIndependent Chairman of the Board
- DDDiantha DuvallCFO and Principal Financial & Accounting Officer
- JBJonathan B. ZungChief Development Officer
- MWMark W. NoelVice President of Technology Management & Intellectual Property
- RBRachel BlasbalgSenior Director of Human Resources
- MRMarc RubinIndependent Director
- JAJohn A. HohnekerIndependent Director
